eXoZymes, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
EXOZ Nasdaq 2836 www.exozymes.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for eXoZymes, Inc.

eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT - Sep 8th, 2026 8:20 am
EXoZymes Inc (EXOZ) (Q2 2026) Earnings Call Highlights: Strategic Pivot and 10x Productivity ... - Aug 21st, 2026 7:03 pm
eXoZymes Q2 Earnings Call Highlights - Aug 20th, 2026 5:02 pm
eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today - Aug 20th, 2026 2:10 pm
eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets - Aug 18th, 2026 2:30 pm
MDB Capital Holdings LLC (MDBH) (Q2 2026) Earnings Call Highlights: Strategic Pivots and Asset ... - Aug 17th, 2026 7:04 pm
MDB Capital Holdings Provides Second Quarter 2026 Update - Aug 13th, 2026 2:05 pm
eXoZymes to Host Second Quarter 2026 Update Conference Call on Thursday, August 20, 2026 - Aug 11th, 2026 2:10 pm
Q2 Virtual Investor Summit Presentations Now Available On Demand - Jun 30th, 2026 11:20 am
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery - Jun 24th, 2026 2:10 pm
Q2 Investor Summit Virtual Live Wednesday June 24 - Jun 23rd, 2026 1:40 pm
eXoZymes Inc. Announces Closing of $6 Million Public Offering - Jun 17th, 2026 2:10 pm
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants - Jun 8th, 2026 7:00 am
eXoZymes Announces Graduation from Shell GameChanger(TM) Accelerator Powered by NLR (GCxN) Program - May 7th, 2026 7:05 am
eXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanufacturing on Grow Everything Podcast - Apr 10th, 2026 7:10 am
MDB Capital Holdings LLC (MDBH) Q4 2025 Earnings Call Highlights: Strategic Innovations and ... - Apr 6th, 2026 7:00 pm
EXoZymes Inc (EXOZ) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Mar 31st, 2026 9:02 pm
eXoZymes Provides Fourth Quarter and Full Year 2025 Update - Mar 31st, 2026 2:20 pm